Article info

PDF
Frequency and reliability of oestrogen receptor, progesterone receptor and HER2 in breast carcinoma determined by immunohistochemistry in Australasia: results of the RCPA Quality Assurance Program
  1. Dr Glenn D Francis, Queensland Health Pathology Service, Princess Alexandra Hospital, Ipswich Rd, Woolloongabba, Queensland, Australia 4102; Glenn_Francis{at}health.qld.gov.au
View Full Text

Citation

Francis GD, Dimech M, Giles L, et al
Frequency and reliability of oestrogen receptor, progesterone receptor and HER2 in breast carcinoma determined by immunohistochemistry in Australasia: results of the RCPA Quality Assurance Program

Publication history

  • Accepted January 8, 2007
  • First published January 26, 2007.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.